[logo] HealthTree Foundation
search more_vert
close
person Sign In / Create Account

Bay Area Myeloma Roundtable

Bay Area Myeloma Roundtable image

Bay Area Myeloma Roundtable

HealthTree Roundtables for Multiple Myeloma
event Mar 09, 2024 / 08:00AM - 02:30PM PST
link icon facebook logo X logo linkedin logo reddit logo email icon

Event Description

Join us for the Bay Area Myeloma Round Table at the Sheraton Palo Alto, March 9th from 9:00 am-2:30 pm PST to hear from top myeloma researchers from the University of California at San Francisco. The day includes informative and engaging presentations about the latest in myeloma as well as breakout sessions for both newly diagnosed and relapsed/refractory patients. The event will feature two sessions that include extensive Q&A. Registration opens at 8:00 am.

 

Special Thanks to our HealthTree Round Table for Multiple Myeloma Sponsors! 

Highlights

Advancement of Life-Changing Care for the Newly Diagnosed Myeloma Patient |Bay Area RT March 9, 2024

expand_more

The Bounty of Treatments for Early Relapsed Myeloma | Bay Area RT March 9, 2024

expand_more

T-Cell Re-Direction Therapy | Bay Area RT March 9, 2024

expand_more

Myeloma Basics for SMM and NDMM Patients | Bay Area RT March 9, 2024

expand_more

Relapsed/Refractory Myeloma: The Chess Game of Therapy Choices | Bay Area RT March 9, 2024

expand_more

Exploring the Myeloma Toolbox | Bay Area RT March 9, 2024

expand_more

Audience Q&A with Faculty Q&A | Bay Area RT March 9, 2024

expand_more

Speakers & Moderators

The panelist Ajai Chari, MD
Ajai Chari, MD

Ajai Chari, M.D. is the Director of the Multiple Myeloma Program and a Professor of Clinical Medicine at the University of California, San Francisco. Dr. Chari’s research interests include the development of novel chemotherapy regimens, including Phase 1 and 2 studies. He has served as the principal investigator (PI) of several investigator-initiated trials as well as the national and international PI of several industry-sponsored studies. With a long standing dedication to research, Dr Chari has been involved in each of the therapies approved in multiple myeloma over the last two decades. He has published numerous articles in the field and is a frequently invited speaker at national and international meetings. Dr. Chari received undergraduate degree from Stanford University and his medical degree from the David Geffen School of Medicine at University of California – Los Angeles. He completed his residency in internal medicine at Columbia University Medical Center and a fellowship in hematology and oncology at the University of California – San Francisco.

Read Bio
The panelist Jeffrey L. Wolf, MD
Jeffrey L. Wolf, MD
San Francisco, CA

Dr. Jeffrey L. Wolf is a hematologist with expertise in cancers of the bone marrow and blood, as well as in bone marrow transplantation to treat these cancers. His primary focus in both patient care and research is myeloma, the second most common blood cancer. He directs UCSF's Multiple Myeloma Program and the Stephen and Nancy Grand Multiple Myeloma Translational Initiative – a program to support the development of better treatments – at the UCSF Helen Diller Family Comprehensive Cancer Center. Wolf's current research interests are in measuring minimal residual disease in patients who have undergone successful treatment for myeloma, as the results are useful in predicting long-term survival. Wolf earned his medical degree at the University of Illinois College of Medicine at Chicago and completed a residency in medicine at the University of California, San Diego. He completed a fellowship in hematology and oncology at UCSF, followed by a bone marrow transplantation rotation at the Fred Hutchinson Cancer Research Center. In 1979, Wolf helped establish the bone marrow transplant program at the City of Hope Comprehensive Cancer Center in Duarte, California. In 1984, he helped establish the first bone marrow transplant unit based at a community hospital in the United States, at Alta Bates Summit Medical Center in Berkeley. He joined UCSF in 2007.

Read Bio
The panelist Jennifer Ahlstrom
Jennifer Ahlstrom

Myeloma survivor, patient advocate, wife, mom of 6. Believer that patients can help accelerate a cure by weighing in and participating in clinical research. Founder of the HealthTree Foundation.

Read Bio
The panelist Alfred Chung, MD
Alfred Chung, MD

Dr. Alfred Chung is a hematologist-oncologist who cares for patients with blood cancers, including leukemias, lymphomas and myelomas. He sees patients who are in the hospital for treatment, including those who need a bone marrow transplant and those receiving chemotherapy or cellular therapies to bolster the immune system. Chung's research centers on the study and development of new therapies for plasma cell disorders, including multiple myeloma and amyloidosis (buildup of an abnormal protein called amyloid in the organs). One specific area of study is light chain amyloidosis, in which the dysfunction of certain antibody-producing cells results in abnormal protein fibers in the organs. Chung is looking specifically at targeted therapies to treat this type of amyloidosis as well as novel therapeutic strategies in the treatment of multiple myeloma. After earning a bachelor's degree in chemical engineering at the University of Michigan, Chung earned a medical degree at Northwestern University Feinberg School of Medicine. At Stanford Medicine, he completed a residency in internal medicine, followed by a fellowship in hematology and oncology. Chung is a member of the American Society of Clinical Oncology, American Society of Hematology and Association of Northern California Oncologists.

Read Bio
The panelist Nancy Sze Wan Wong, NP, MSN
Nancy Sze Wan Wong, NP, MSN

Nancy Sze Wan Wong is a nurse practitioner who cares for patients with blood disorders. Her expertise includes chronic blood disorders that surface suddenly and require immediate treatment. Wong is passionate about caring for patients with cancers of the blood. She aims to help her patients learn more about their condition in addition to helping them manage their symptoms during recovery. Wong earned her master's degree in nursing at Samuel Merritt University. She is a member of the Oncology Nursing Society. A native of San Francisco, Wong enjoys spending time with her family, reading and hiking.

Read Bio
The panelist Grace Sevilla, PA
Grace Sevilla, PA

Grace Sevilla is a dedicated physician assistant with a passion for providing compassionate care for her patients with hematological malignancies. She holds a Master's degree in Physician Assistant Studies from Pacific University in Oregon. Prior to working for UCSF, Grace’s professional journey led her to work as an advance practice provider at the forefront of cancer research and treatment at Fred Hutch Cancer Center in Seattle, WA. With a focus in multiple myeloma, she is committed to staying abreast of the latest advancements and treatments in her field. Grace takes great pride in fostering meaningful relationships with her patients, recognizing the importance of empathy, and understanding in their healing journey. Although an East Coast native, she considers herself a West Coaster in all things except football and crabs.

Read Bio
The panelist Anupama Kumar, MD
Anupama Kumar, MD

Dr. Anupama Kumar is an Assistant Professor of Medicine at UCSF in the Hematology, Blood and Marrow Transplant, and Cellular Therapy program. Her clinical practice and research focuses on multiple myeloma. She leads clinical trials providing patients access to new therapies. She is also interested in healthcare disparities. Dr. Kumar's work contributes to the broader understanding of cancer treatment strategies and patient care. Seasoned professional with over 10 years of translational research expertise in cancer biology, immune-oncology, molecular pathology and cancer genetics seamlessly integrating academic and industrial experience. My passion lies in interpreting clinical data, identifying candidate biomarkers, and validating hypotheses using experimental models. This drive fuels my commitment to developing safe and effective therapeutic approaches for cancer patients.

Read Bio

Location

Sheraton Palo Alto Hotel

625 El Camino Real, Palo Alto, CA 94301, USA

Have Any Questions?

Thank you for your interest in the event. If you have any questions, we would love to help!

Feel free to give us a call or send us a message below.

support

Get In Touch With Us

phone

1-800-709-1113

email

Support@healthtree.org

newsletter icon

Get the latest thought leadership on your Multiple Myeloma delivered straight to your inbox

Subscribe to the weekly newsletter for news, stories, clinical trial updates, and helpful resources and events with cancer experts.

Thanks to our HealthTree Community for Multiple Myeloma Sponsors:

Johnson and Johnson
Sanofi
Pfizer
Genentech
Regeneron
Adaptive

Follow Us

facebook instagram linkedin tiktok youtube